EDGAR Filing Documents for 0000812796-07-000052

Form 8-K - Current report:

SEC Accession No. 0000812796-07-000052

Filing Date

2007-06-22

Accepted

2007-06-22 15:48:31

Documents

Period of Report

2007-06-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8K FOR RIGHTS AGREEMENT	rightsagreement8k.htm	8-K	56772
2	CERTIFICATE OF DESIGNATION OF PREFERRED STOCK	certofdesignation.htm	EX-3.1	56252
3	RIGHTS AGREEMENT	rightsagreement.htm	EX-4.1	280940
4	FORM OF RIGHT OF CERTIFICATE	formofrightcert.htm	EX-4.2	32467
5	PRESS RELEASE OF RIGHTS AGREEMENT	pressreleaserightagree.htm	EX-99.1	17597
	Complete submission text file	0000812796-07-000052.txt		445825

Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131

Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383

DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)